What Has Been the Growth Trajectory of the Renal Denervation Devices Market?
The renal denervation devices market has seen considerable growth due to a variety of factors.
•The market size for renal denervation devices has experienced a significant increase lately. It is projected to grow from $0.55 billion in 2024 to $0.74 billion in 2025, with a robust compound annual growth rate (CAGR) of 34.0%.
The past period's expansion can be linked to a rise in hypertension incidents, clinical research and surveys, a surge in cardiovascular illnesses, initial FDA authorization, regulatory advancements, and the introduction of renal denervation systems into the market.
What Does the Future Hold for the Renal Denervation Devices Market?
The renal denervation devices market is expected to maintain its strong growth trajectory in upcoming years.
• It is anticipated that the renal denervation devices market will experience substantial growth in the coming years, ballooning to "$2.28 billion by 2029, with a compound annual growth rate (CAGR) of 32.3%.
The projected increase in the said period can be linked to factors such as a patient-oriented approach, enhancements in healthcare infrastructural, increased awareness and acceptance, focus on less intrusive therapies, and introduction of new devices into the market. Some of the main trends expected to emerge during this period include the incorporation of artificial intelligence (AI) and machine learning, evolving regulatory landscape, shift towards less invasive procedures, the importance placed on clinical evidence, and the inclusion of remote monitoring and telehealth.
What Are The Leading Drivers Of Growth In The Renal Denervation Devices Market?
The rise in hypertension cases is anticipated to catalyze the expansion of the renal denervation devices market. Hypertension, otherwise known as elevated blood pressure, manifests as a consistently excessive force of blood coursing through the blood vessels. Renal denervation, a catheter-based procedure, has surfaced as a potential resistance to hypertension in patients, particularly served as a minimally invasive option for hypertension that remains unaffected by medication. For example, the Centers for Disease Control and Prevention, a US government entity, reported in May 2024 that high blood pressure was implicated in or outright caused 685,875 deaths in the US in 2022. Hence, the rise in hypertension cases is predicted to spur the expansion of the renal denervation devices market.
How Are The Segments Defined Within The Global Renal Denervation Devices Market?
The renal denervation devices market covered in this report is segmented –
1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products
2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Brachytherapy, Chemical Ablation, Other Technologies
3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users
Subsegments:
1) By Simplicity Renal Denervation System: Catheter System, Accessories
2) By EnligHTN: Catheter System, Generator, Accessories
3) By Vessix Renal Denervation System: Balloon Catheter, Generator, Accessories
4) By Iberis Renal Sympathetic Denervation System: Catheter System, Accessories
5) By Paradise Renal Denervation System: Catheter System, Accessories
6) By Other Products: Emerging Technologies, Alternative Devices
Pre-Book The Renal Denervation Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Renal Denervation Devices Market?
Renal denervation devices market's key players are concentrating their efforts on the advancement of ultrasound renal denervation (uRDN) technology. The aim is to improve treatment outcomes, minimize procedure-related complications, and offer a non-invasive alternative to standard renal denervation methodologies. uRDN upgrades renal denervation devices by ensuring precise, non-invasive energy distribution to the renal nerves. This mechanism effectively reduces blood pressure while shielding surrounding tissues, thereby boosting patient safety and comfort during the procedure. An illustration of this is the launch of Paradise uRDN system by Recor Medical Inc., a US medical tech firm, in November 2023. This cutting-edge ultrasound renal denervation apparatus is engineered to manage hypertension in patients who haven't met their blood pressure targets through regular lifestyle modifications and medications. Equipped with hydrocooling technology to safeguard the renal artery during the procedure, this system signifies a major step forward in the renal denervation devices market by introducing a novel, non-drug treatment method for resistant hypertension and broadening therapy alternatives for patients.
Who Are the Key Players in the Renal Denervation Devices Market?
Major companies operating in the renal denervation devices market include:
• Medtronic PLC
• ReCor Medical Inc.
• Boston Scientific Corporation
• Abbott Laboratories
• Cordis Corporation
• Terumo Corporation
• Kona Medical Inc.
• St. Jude Medical LLC
• Johnson & Johnson
• Mercator MedSystems Inc.
• Symple Surgical Inc.
• Ablative Solutions Inc.
• Cardiosonic Ltd.
• Renal Dynamics Ltd.
• Vesalio LLC
• Atricure Inc.
• Biosense Webster Inc.
• Biotronik SE & Co. KG
• Cook Medical LLC
• Hansen Medical Inc.
• Merit Medical Systems Inc.
• AngioDynamics Inc.
• Covidien Ltd.
• Volcano Corporation
• Edwards Lifesciences Corporation
• InnoVein Inc.
• Teleflex Incorporated
• Medinol Ltd.
• Oscor Inc.
• Balton Sp. z o.o.
What Is The Most Dominant Region In The Renal Denervation Devices Market?
Europe was the largest region in the renal denervation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
